LRRK2
突变
遗传学
疾病
外显子
帕金森病
孟德尔遗传
医学
生物
基因
病理
作者
William P. Gilks,Patrick M. Abou‐Sleiman,Sonia Gandhi,Shushant Jain,Andrew Singleton,Andrew J. Lees,Karen Shaw,Kailash P. Bhatia,Vincenzo Bonifati,Niall Quinn,John B. Lynch,Daniel G. Healy,Janice L. Holton,Tamás Révész,Nicholas Wood
出处
期刊:The Lancet
[Elsevier]
日期:2005-01-01
卷期号:365 (9457): 415-416
被引量:606
标识
DOI:10.1016/s0140-6736(05)17830-1
摘要
Summary
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant Parkinson's disease. Few mutations in this gene have been identified. We investigated the frequency of a common heterozygous mutation, 2877510G→A, which produces a glycine to serine aminoacid substitution at codon 2019 (Gly2019Ser), in idiopathic Parkinson's disease. We assessed 482 patients with the disorder, of whom 263 had pathologically confirmed disease, by direct sequencing for mutations in exon 41 of LRRK2. The mutation was present in eight (1·6%) patients. We have shown that a common single Mendelian mutation is implicated in sporadic Parkinson's disease. We suggest that testing for this mutation will be important in the management and genetic counselling of patients with Parkinson's disease. Published online January 18, 2005 http://image.thelancet.com/extras/04let12032web.pdf
科研通智能强力驱动
Strongly Powered by AbleSci AI